24時間医学で考える脳神経内科　患者の1日を通して診る

出版社： 中外医学社
著者：
発行日： 2022-06-30
分野： 臨床医学：内科  >  脳神経科学/神経内科学
ISBN： 9784498328884
電子書籍版： 2022-06-30 （1版1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：4～8営業日

2,640 円(税込)

購入する
電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

2,640 円(税込)

購入する

商品紹介

すべての患者は眠る．しかしながら，そして当然ではあるが，診療の重きは覚醒時の症状に置かれる．その覚醒時の症状，実は睡眠時に原因がないだろうか？ 睡眠と覚醒は互いに影響を及ぼす表裏一体の関係である．脳血管障害，てんかん症候群，認知症，パーキンソン病，不随意運動などを睡眠医学の視点で捉え直すことで，現場での新たな引き出しを臨床医に提供する．“あの患者の夜”を知ることで，昼の診療が大きく変わるはずである．

目次

  • CHAPTER　0　24時間医学の概念を取り入れるべし
    CHAPTER　1　24時間医学で考える脳血管障害
    CHAPTER　2　24時間医学で考える筋強直性ジストロフィー
    CHAPTER　3　24時間医学で考える重症筋無力症
    CHAPTER　4　24時間医学で考える筋萎縮性側索硬化症
    CHAPTER　5　24時間医学で考える多発性硬化症
    CHAPTER　6　24時間医学で考えるてんかん症候群
    CHAPTER　7　24時間医学で考える認知症
    CHAPTER　8　24時間医学で考える脊髄損傷
    CHAPTER　9　24時間医学で考える頭痛
    CHAPTER　10　24時間医学で考えるパーキンソン病
    CHAPTER　11　24時間医学で考える不随意運動
    CHAPTER　12　24時間医学で考える末梢神経障害

    Column
    患者だけの24時間医学ではない．医療従事者の側も24時間医学で考えろ．
    対症療法を一段下げて考えていないか？

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

CHAPTER 1 24時間医学で考える脳血管障害

P.18 掲載の参考文献
1) 日本脳卒中学会 脳卒中医療向上・社会保険委員会 静注血栓溶解療法指針改訂部会. 静注血栓溶解 (rt-PA) 療法 適正治療指針 第3版. 脳卒中. 2019 ; 41 : 205-46.
 
2) Scullin MK, Bliwise DL. Sleep, cognition, and normal aging : integrating a half century of multidisciplinary research. Perspect Psychol Sci. 2015 ; 10 : 97-137.
PubMed
3) Elliott WJ. Circadian variation in the timing of stroke onset : a meta-analysis. Stroke. 1998 ; 29 : 992-6.
PubMed
4) Viskin S, Golovner M, Malov N, et al. Circadian variation of symptomatic paroxysmal atrial fibrillation. Data from almost 10000 episodes. Eur Heart J. 1999 ; 20 : 1429-34.
 
5) Yamashita T, Murakawa Y, Sezaki K, et al. Circadian variation of paroxysmal atrial fibrillation. Circulation. 1997 ; 96 : 1537-41.
PubMed
6) Almeneessier AS, Alshahrani M, Aleissi S, et al. Comparison between blood pressure during obstructive respiratory events in ReM and nReM sleep using pulse transit time. Sci Rep. 2020 ; 10 : 1-10.
PubMed
7) Seiler A, Camilo M, Korostovtseva L, et al. Prevalence of sleep-disordered breathing after stroke and TIA : a meta-analysis. Neurology. 2019 ; 92 : e648-54.
 
8) Brown DL, McDermott M, Mowla A, et al. Brainstem infarction and sleep-disordered breathing in the BASIC sleep apnea study. Sleep Med. 2014 ; 15 : 887-91.
PubMed
9) Martinez-Garcia MA, Galiano-Blancart R, Soler-Cataluna J-J, et al. Improvement in nocturnal disordered breathing after first-ever ischemic stroke : role of dysphagia. Chest. 2006 ; 129 : 238-45.
PubMed
10) Tomfohr LM, Hemmen T, Natarajan L, et al. Continuous positive airway pressure for treatment of obstructive sleep apnea in stroke survivors : what do we really know? Stroke. 2012 ; 43 : 3118-23.
PubMed
11) Siccoli MM, Valko PO, Hermann DM, et al. Central periodic breathing during sleep in 74 patients with acute ischemic stroke-neurogenic and cardiogenic factors. J Neurol. 2008 ; 255 : 1687-92.
PubMed
12) Brill AK, Rosti R, Hefti JP, et al. Adaptive servo-ventilation as treatment of persistent central sleep apnea in post-acute ischemic stroke patients. Sleep Med. 2014 ; 15 : 1309-13.
PubMed

CHAPTER 2 24時間医学で考える筋強直性ジストロフィー

P.25 掲載の参考文献
1) Heatwole C, Bode R, Johnson N, et al. Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1). Neurology. 2012 ; 79 : 348-57.
 
2) Gibbs JW, 3rd, Ciafaloni E, Radtke RA. Excessive daytime somnolence and increased rapid eye movement pressure in myotonic dystrophy. Sleep. 2002 ; 25 : 662-5.
PubMed
3) Bonanni E, Carnicelli L, Crapanzano D, et al. Disruption of sleep-wake continuum in myotonic dystrophy type 1 : beyond conventional sleep staging. Neuromuscul Disord. 2018 ; 28 : 414-21.
PubMed
4) MacDonald JR, Hill JD, Tarnopolsky MA. Modafinil reduces excessive somnolence and enhances mood in patients with myotonic dystrophy. Neurology. 2002 ; 59 : 1876-80.
PubMed
5) 鈴木幹也, 大矢寧, 川井充. 筋強直性ジストロフィー患者の日中過眠に対するmodafinil投与経験～その効果と副作用～. 臨床神経. 2010 ; 50 : 578-80.
 
6) Aboussouan LS, Mireles-Cabodevila E. Sleep-disordered breathing in neuromuscular disease : diagnostic and therapeutic challenges. Chest. 2017 ; 152 : 880-92.
PubMed
7) Paunic T, Peric S, Cvitan E, et al. Routine echocardiography in patients with myotonic dystrophy type 1. J Chin Med Assoc. 2017 ; 80 : 408-12.
PubMed

CHAPTER 3 24時間医学で考える重症筋無力症

P.31 掲載の参考文献
1) Tascilar NF, Saracli O, Kurcer MA, et al. Is there any relationship between quality of life and polysomnographically detected sleep parameters/disorders in stable myasthenia gravis? Acta Neurol Belg. 2018 ; 118 : 29-37.
PubMed
2) Heo SJ, Jun JS, Park D, et al. Characteristics of obstructive sleep apnea in myasthenia gravis patients : a single center study. Neurol Sci. 2019 ; 40 : 719-24.
PubMed
3) Seneviratne J, Mandrekar J, Wijdicks EF, et al. Noninvasive ventilation in myasthenic crisis. Arch Neurol. 2008 ; 65 : 54-8.
PubMed
4) Nakata R, Motomura M, Masuda T, et al. Thymus histology and concomitant autoimmune diseases in Japanese patients with muscle-specific receptor tyrosine kinase-antibody-positive myasthenia gravis. Eur J Neurol. 2013 ; 20 : 1272-6.
PubMed
5) Rabinstein AA. Noninvasive ventilation for neuromuscular respiratory failure : when to use and when to avoid. Curr Opin Crit Care. 2016 ; 22 : 94-9.
PubMed
6) Gajdos P, Chevret S, Clair B, et al. Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Myasthenia Gravis Clinical Study Group. Ann Neurol. 1997 ; 41 : 789-96.
PubMed
7) Bae JS, Go SM, Kim BJ. Clinical predictors of steroid-induced exacerbation in myasthenia gravis. J Clin Neurosci. 2006 ; 13 : 1006-10.
PubMed

CHAPTER 4 24時間医学で考える筋萎縮性側索硬化症

P.39 掲載の参考文献
1) Boentert M, Brenscheidt I, Glatz C, et al. Effects of non-invasive ventilation on objective sleep and nocturnal respiration in patients with amyotrophic lateral sclerosis. J Neurol. 2015 ; 262 : 2073-82.
PubMed
2) Berlowitz DJ, Howard ME, Fiore JF Jr, et al. Identifying who will benefit from non-invasive ventilation in amyotrophic lateral sclerosis/motor neurone disease in a clinical cohort. J Neurol Neurosurg Psychiatry. 2015 ; 87 : 280-6.
 
3) Bourke SC, Tomlinson M, Williams TL, et al. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis : a randomised controlled trial. Lancet Neurol. 2006 ; 5 : 140-7.
PubMed
4) Miller RG, Jackson CE, Kasarskis EJ, et al. Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter update : the care of the patient with amyotrophic lateral sclerosis : drug, nutritional, and respiratory therapies (an evidence-based review) : report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009 ; 73 : 1218-26. Erratum in : Neurology. 2009 ; 73 : 2134. Erratum in : Neurology. 2010 ; 74 : 781.
 
5) Vitacca M, Montini A, Lunetta C, et al. ALS RESPILOM Study Group. Impact of an early respiratory care programme with non-invasive ventilation adaptation in patients with amyotrophic lateral sclerosis. Eur J Neurol. 2018 ; 25 : 556-e33.
 
6) Thakore NJ, Lapin BR, Pioro EP, et al. Variation in noninvasive ventilation use in amyotrophic lateral sclerosis. Neurology. 2019 ; 93 : e306-16.
PubMed
7) Lo Coco D, Mattaliano P, Spataro R, et al. Sleep-wake disturbances in patients with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2011 ; 82 : 839-42.
PubMed
8) Stephens HE, Joyce NC, Oskarsson B. National study of muscle cramps in ALS in the USA. Amyotroph Lateral Scler Frontotemporal Degener. 2017 ; 18 : 32-6. Erratum in : Amyotroph Lateral Scler Frontotemporal Degener. 2017 ; 18 : 470.
 
9) Caress JB, Ciarlone SL, Sullivan EA, et al. Natural history of muscle cramps in amyotrophic lateral sclerosis. Muscle Nerve. 2016 ; 53 : 513-7.
PubMed
10) Stephens HE, Lehman E, Raheja D, et al. The role of mental health and self-efficacy in the pain experience of patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2016 ; 17 : 206-12.
PubMed
11) 日本神経内科学会, 監修. 筋萎縮性側索硬化症診療ガイドライン 2013. 南江堂 ; 2013.
 

CHAPTER 5 24時間医学で考える多発性硬化症

P.47 掲載の参考文献
1) Krupp L. In : Hohlfeld R, et al. editors. Multiple sclerosis : clinical challenges and controversies. Informa Healthcare ; 1997. p.283-94.
 
2) 日本神経学会, 監修. 多発性硬化症・視神経脊髄炎診療ガイドライン 2017. 医学書院 ; 2017. 第14章.
 
3) Stanton B, Barnes F, Silber E. Sleep and fatigue in multiple sclerosis. Mult Scler. 2006 ; 12 : 481-6.
PubMed
4) Merkelbach S, Schulz H, Kolmel H, et al. Fatigue, sleepiness, and physical activity in patients with multiple sclerosis. J Neurol. 2011 ; 258 : 74-9.
PubMed
5) Kaminska M, Kimoff R, Benedetti A, et al. Obstructive sleep apnea is associated with fatigue in multiple sclerosis. Mult Scler. 2012 ; 18 : 1159-69.
PubMed
6) Braley TJ, Segal BM, Chervin RD. Sleep-disordered breathing in multiple sclerosis. Neurology. 2012 ; 79 : 929-36.
PubMed
7) Kallweit U, Bassetti CL, Oberholzer M, et al. Coexisting narcolepsy (with and without cataplexy) and multiple sclerosis. J Neurol. 2018 ; 265 : 2071-8.
PubMed
8) Siengsukon CF, Aldughmi M, Kahya M, et al. Randomized controlled trial of exercise interventions to improve sleep quality and daytime sleepiness in individuals with multiple sclerosis : a pilot study. Mult Scler. 2016 ; 2 : 1-9.
 

CHAPTER 6 24時間医学で考えるてんかん症候群

P.56 掲載の参考文献
1) Badawy RA, Freestone DR, Lai A, et al. Epilepsy : ever-changing states of cortical excitability. Neuroscience. 2012 ; 222 : 89-99.
PubMed
2) Giorelli AS, Passos P, Carnaval T, et al. Excessive daytime sleepiness and epilepsy : a systematic review. Epilepsy Res Treat. 2013 ; 2013 : 629469.
PubMed
3) Foley DJ, Monjan AA, Brown SL, et al. Sleep complaints among elderly persons : an epidemiologic study of three communities. Sleep. 1995 ; 18 : 425-32.
PubMed
4) Hollinger P, Khatami R, Gugger M, et al. Epilepsy and obstructive sleep apnea. Eur Neurol. 2006 ; 55 : 74-9.
PubMed
5) Malow BA, Weatherwax KJ, Chervin RD, et al. Identification and treatment of obstructive sleep apnea in adults and children with epilepsy : a prospective pilot study. Sleep Med. 2003 ; 4 : 509-15.
PubMed
6) Tassinari CA, Rubboli G, Gardella E, et al. Central pattern generators for a common semiology in fronto-limbic seizures and in parasomnias. A neuroethologic approach. Neurol Sci. 2005 ; 26 Suppl 3 : s225-32.
PubMed

CHAPTER 7 24時間医学で考える認知症

P.65 掲載の参考文献
1) Ohayon MM, Carskadon MA, Guilleminault C, et al. Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals : developing normative sleep values across the human lifespan. Sleep. 2004 ; 27 : 1255-73.
PubMed
2) Foley DJ, Monjan AA, Brown SL, et al. Sleep complaints among elderly persons : an epidemiologic study of three communities. Sleep. 1995 ; 18 : 425-32.
PubMed
3) Volicer L, Harper DG, Manning BC, et al. Sundowning and circadian rhythms in Alzheimer's disease. Am J Psychiatry. 2001 ; 158 : 704-11.
PubMed
4) Dowling GA, Burr RL, Van Someren EJ, et al. Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease. J Am Geriatr Soc. 2008 ; 56 : 239-46.
 
5) Mishima K, Okawa M, Hozumi S, et al. Supplementary administration of artificial bright light and melatonin as potent treatment for disorganized circadian rest-activity and dysfunctional autonomic and neuroendocrine systems in institutionalized demented elderly persons. Chronobiol Int. 2000 ; 17 : 419-32.
PubMed
6) Venturelli M, Sollima A, Ce E, et al. Effectiveness of exercise- and cognitive-based treatments on salivary cortisol levels and sundowning syndrome symptoms in patients with Alzheimer's disease. J Alzheimers Dis. 2016 ; 53 : 1631-40.
 

CHAPTER 8 24時間医学で考える脊髄損傷

P.74 掲載の参考文献
1) Sankari A, Badr MS, Martin JL, et al. Impact of spinal cord injury on sleep : current perspectives. Nat Sci Sleep. 2019 ; 11 : 219.
PubMed
2) Biering-Sorensen F, Biering-Sorensen M. Sleep disturbances in the spinal cord injured : an epidemiological questionnaire investigation, including a normal population. Spinal Cord. 2001 ; 39 : 505-13.
PubMed
3) Berlowitz DJ, Spong J, Gordon I, et al. Relationships between objective sleep indices and symptoms in a community sample of people with tetraplegia. Arch Phys Med Rehabil. 2012 ; 93 : 1246-52.
 
4) Zeitzer JM, Ayas NT, Shea SA, et al. Absence of detectable melatonin and preservation of cortisol and thyrotropin rhythms in tetraplegia. J Clin Endocrinol Metab. 2000 ; 85 : 2189-96.
PubMed
5) Kostovski E, Frigato E, Savikj M, et al. Normalization of disrupted clock gene expression in males with tetraplegia : a crossover randomized placebo-controlled trial of melatonin supplementation. Spinal Cord. 2018 ; 56 : 1076-83.
PubMed
6) Zeitzer JM, Ku B, Ota D, et al. Randomized controlled trial of pharmacological replacement of melatonin for sleep disruption in individuals with tetraplegia. J Spinal Cord Med. 2014 ; 37 : 46-53.
PubMed
7) Crane BR. Nature's intricate clockwork. Science. 2012 ; 337 : 165-6.
 
8) Kumru H, Vidal J, Benito J, et al. Restless leg syndrome in patients with spinal cord injury. Parkinsonism Relat Disord. 2015 ; 21 : 1461-4.
PubMed
9) Telles SC, Alves RC, Chadi G. Periodic limb movements during sleep and restless legs syndrome in patients with ASIA A spinal cord injury. J Neurol Sci. 2011 ; 303 : 119-23.
 
10) Montplaisir J, Boucher S, Poirier G, et al. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome : a study of 133 patients diagnosed with new standard criteria. Movement Disorders. 1997 ; 12 : 61-5.
 
11) Hornyak M, Feige B, Riemann D, et al. Periodic leg movements in sleep and periodic limb movement disorder : prevalence, clinical significance and treatment. Sleep Med Rev. 2006 ; 10 : 169-77.
PubMed

CHAPTER 9 24時間医学で考える頭痛

P.81 掲載の参考文献
1) Solomon GD. Circadian rhythms and migraine. Cleve Clin J Med. 1992 ; 59 : 326-9.
PubMed
2) Fox AW, Davis RL. Migraine chronobiology. Headache. 1998 ; 38 : 436-41.
PubMed
3) Peres MF, Sanchez del Rio M, Seabra ML, et al. Hypothalamic involvement in chronic migraine. J Neurol Neurosurg Psychiatry. 2001 ; 71 : 747-51.
 
4) Kelman L, Rains JC. Headache and sleep : examination of sleep patterns and complaints in a large clinical sample of migraineurs. Headache. 2005 ; 45 : 904-10.
 
5) Alstadhaug K, Salvesen R, Bekkelund S. Insomnia and circadian variation of attacks in episodic migraine. Headache. 2007 ; 47 : 1184-8.
PubMed
6) Rains JC, Poceta JS. Sleep-related headaches. Neurol Clin. 2012 ; 30 : 1285-98.
PubMed
7) Yin JH, Chen SY, Lin CC, et al. Increased risk of sleep apnoea among primary headache disorders : a nationwide population-based longitudinal study. Postgrad Med J. 2019 ; 95 : 72-7.
PubMed
8) Johnson KG, Ziemba AM, Garb JL. Improvement in headaches with continuous positive airway pressure for obstructive sleep apnea : a retrospective analysis. Headache. 2013 ; 53 : 333-43.
PubMed
9) Nath Zallek S, Chervin RD. Improvement in cluster headache after treatment for obstructive sleep apnea. Sleep Med. 2000 ; 1 : 135-8.
PubMed
10) Smitherman TA, Walters AB, Davis RE, et al. Randomized controlled pilot trial of behavioral insomnia treatment for chronic migraine with comorbid insomnia. Headache. 2016 ; 56 : 276-91.
PubMed
11) Farney RJ, Walker BS, Farney RM, et al. The STOP-Bang equivalent model and prediction of severity of obstructive sleep apnea : relation to polysomnographic measurements of the apnea/hypopnea index. J Clin Sleep Med. 2011 ; 7 : 459-65B.
PubMed

CHAPTER 10 24時間医学で考えるパーキンソン病

P.90 掲載の参考文献
1) St Louis EK, Boeve BF. REM sleep behavior disorder : diagnosis, clinical implications, and future directions. Mayo Clin Proc. 2017 ; 92 : 1723-36.
PubMed
2) 下畑享良, 井上雄一, 平田幸一. Rapid eye movement (REM) 睡眠行動障害の診断, 告知, 治療. 臨床神経. 2017 ; 57 : 63-70.
 
3) Stiasny-Kolster K, Mayer G, Schafer S, et al. The REM sleep behavior disorder screening questionnaire--a new diagnostic instrument. Movement Disorders. 2007 ; 22 : 2386-93.
 
4) 日本神経内科学会, 監修. パーキンソン病診療ガイドライン 2018. 医学書院 ; 2018.
 
5) Kidron D, Melamed E. Forms of dystonia in patients with Parkinson's disease. Neurology. 1987 ; 37 : 1009-11.
PubMed

CHAPTER 11 24時間医学で考える不随意運動

P.96 掲載の参考文献
1) 坂田英明, 加我君孝. Oculopalatal myoclonus症例とPalatal myoclonus症例の比較電気眼振図と聴性脳幹反応による検討. Equilibrium Res. 1994 ; 53 : 495-502.
 
2) Silvestri RC. Chapter 39 persistence of daytime movement disorders during sleep. In : Chokroverty S, et al. editors. Sleep and movement disorders. 2nd ed. Oxford University Press ; 2013. p.535-45.
 
3) Silber MH. Sleep-related movement disorders. Continuum (Minneapolis, Minn). 2013 ; 19 : 170-84.
 
4) Sateia MJ. International classification of sleep disorders-3rd edition : highlights and modifications. Chest. 2014 ; 146 : 1387-94.
 

CHAPTER 12 24時間医学で考える末梢神経障害

P.102 掲載の参考文献
1) Odrcich M, Bailey JM, Cahill CM, et al. Chronobiological characteristics of painful diabetic neuropathy and postherpetic neuralgia : diurnal pain variation and effects of analgesic therapy. Pain. 2006 ; 120 : 207-12.
PubMed
2) Gilron I, Bailey JM, Vandenkerkhof EG. Chronobiological characteristics of neuropathic pain : clinical predictors of diurnal pain rhythmicity. Clin J Pain. 2013 ; 29 : 755-9.
PubMed
3) Gilron I, Ghasemlou N. Chronobiology of chronic pain : focus on diurnal rhythmicity of neuropathic pain. Curr Opin Support Palliat Care. 2014 ; 8 : 429-36.
PubMed
4) Foley DJ, Monjan AA, Brown SL, et al. Sleep complaints among elderly persons : an epidemiologic study of three communities. Sleep. 1995 ; 18 : 425-32.
PubMed
5) Jimenez FJ, Alonso, Navarro H, et al. Association between restless legs syndrome and peripheral neuropathy : a systematic review and meta-analysis. Eur J Neurol. 2021 ; 28 : 2423-42.
 
6) International classification of sleep disorders. 3rd ed. American Academy of Sleep Medicine ; 2014.
 
7) Kalra S, Gupta A. Diabetic painful neuropathy and restless legs syndrome in diabetes. Springer ; 2018.
 

書評

最近チェックした商品履歴

Loading...